Inspire Medical Systems Current Ratio 2017-2025 | INSP
Inspire Medical Systems current ratio from 2017 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Inspire Medical Systems Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-12-31 | $0.58B | $0.10B | 6.08 |
| 2025-09-30 | $0.59B | $0.11B | 5.29 |
| 2025-06-30 | $0.57B | $0.09B | 6.14 |
| 2025-03-31 | $0.57B | $0.06B | 9.01 |
| 2024-12-31 | $0.63B | $0.09B | 7.13 |
| 2024-09-30 | $0.58B | $0.07B | 7.84 |
| 2024-06-30 | $0.61B | $0.07B | 9.25 |
| 2024-03-31 | $0.57B | $0.07B | 7.93 |
| 2023-12-31 | $0.59B | $0.08B | 7.60 |
| 2023-09-30 | $0.57B | $0.07B | 8.14 |
| 2023-06-30 | $0.56B | $0.07B | 8.40 |
| 2023-03-31 | $0.53B | $0.06B | 8.91 |
| 2022-12-31 | $0.53B | $0.06B | 8.66 |
| 2022-09-30 | $0.50B | $0.05B | 10.05 |
| 2022-06-30 | $0.26B | $0.05B | 5.62 |
| 2022-03-31 | $0.26B | $0.04B | 6.08 |
| 2021-12-31 | $0.27B | $0.04B | 6.50 |
| 2021-09-30 | $0.26B | $0.03B | 7.61 |
| 2021-06-30 | $0.25B | $0.02B | 10.25 |
| 2021-03-31 | $0.26B | $0.02B | 13.43 |
| 2020-12-31 | $0.27B | $0.02B | 13.02 |
| 2020-09-30 | $0.27B | $0.02B | 14.67 |
| 2020-06-30 | $0.27B | $0.01B | 20.48 |
| 2020-03-31 | $0.16B | $0.01B | 11.33 |
| 2019-12-31 | $0.17B | $0.02B | 10.12 |
| 2019-09-30 | $0.17B | $0.01B | 13.42 |
| 2019-06-30 | $0.18B | $0.01B | 20.46 |
| 2019-03-31 | $0.19B | $0.01B | 24.09 |
| 2018-12-31 | $0.20B | $0.01B | 17.86 |
| 2018-09-30 | $0.13B | $0.01B | 17.11 |
| 2018-06-30 | $0.13B | $0.01B | 14.24 |
| 2018-03-31 | $0.03B | $0.01B | 3.40 |
| 2017-12-31 | $0.02B | $0.01B | 3.37 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.555B | $0.912B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |